These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11257344)

  • 21. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants.
    Altintaş DU; Evliyaoğlu N; Kilinç B; Sen'an DI; Güneşer S
    Eur J Epidemiol; 1996 Dec; 12(6):647-8. PubMed ID: 8982627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
    J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants.
    Johnson CE; Darbari A; Darbari DS; Nalin D; Whitwell J; Chui LW; Cleves MA; Kumar ML
    Vaccine; 2000 May; 18(22):2411-5. PubMed ID: 10738098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity against measles in populations of women and infants in Poland.
    Janaszek W; Slusarczyk J
    Vaccine; 2003 Jun; 21(21-22):2948-53. PubMed ID: 12798638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 27. Maternally derived measles immunity in era of vaccine-protected mothers.
    Lennon JL; Black FL
    J Pediatr; 1986 May; 108(5 Pt 1):671-6. PubMed ID: 3701511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus.
    Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E
    Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J; Peters N; Hüttermann U; Rieger C
    Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss maternally derived measles immunity in Argentinian infants.
    Nates SV; Giordano MO; Medeot SI; Martínez LC; Baudagna AM; Naretto E; Garrido P; De Wolff CD
    Pediatr Infect Dis J; 1998 Apr; 17(4):313-6. PubMed ID: 9576386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The study of countermeasures on measles control in infants].
    Wang L; Sun L; Jiang Z; Kang S; Liu Y; Jiang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild measles virus strains in vaccinated and naturally infected subjects.
    Cześcik A; Dunal-Szczepaniak M; Trzcińska A; Siennicka J
    Pol J Microbiol; 2014; 63(2):203-9. PubMed ID: 25115114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity.
    Bitzegeio J; Majowicz S; Matysiak-Klose D; Sagebiel D; Werber D
    Euro Surveill; 2019 Apr; 24(17):. PubMed ID: 31039834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of measles immunity among infants in Maputo City, Mozambique.
    Jani JV; Holm-Hansen C; Mussá T; Zango A; Manhiça I; Bjune G; Jani IV
    BMC Public Health; 2008 Nov; 8():386. PubMed ID: 19014485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
    Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
    Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.